Endra Life Sciences Inc Reports Results For The Quarter Ended In March: Earnings Summary

ENDRA Life Sciences

16/05/2023 01:05

* ENDRA Life Sciences Inc  NDRA.OQ  reported a quarterly
adjusted
loss of 93 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of $1.04 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ENDRA Life Sciences Inc's reported EPS for the quarter was
a
loss of 93 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ENDRA Life Sciences Inc shares had fallen by 38.9% this
quarter and lost 65.6% so far this year.
    * The company reported a quarterly loss of $2.94 million.
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $19.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 12:05 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.04          -0.93          Beat
 Dec. 31 2022      -0.90          -0.96          Missed
 Sep. 30 2022      -1.10          -1.00          Beat
 Jun. 30 2022      -1.10          -1.20          Missed